Drug Type Small molecule drug |
Synonyms Metgluna, Mitiglinide/metformin |
Mechanism PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC4H12ClN5 |
InChIKeyOETHQSJEHLVLGH-UHFFFAOYSA-N |
CAS Registry1115-70-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | US | - | |
Diabetes Mellitus, Type 2 | Phase 3 | US | - | |
Diabetes Mellitus, Type 2 | Phase 3 | - | - | |
Diabetes Mellitus, Type 2 | Phase 3 | - | - |